GENE ONLINE|News &
Opinion
Blog

2017-11-07|

November 8, 2012: Completion of the Liver Cancer Genome

by GeneOnline
Share To

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. The whole genome sequence of HCC was completed by RIKEN, a Japanese research institution, and was published on November 8, 2012. The result revealed many new cancer-associated genes, a variety of genomic alterations, and the common integration sites for hepatitis B virus (HBV) genome. The report was a step forward for studying the HBV virus and for developing new drugs for liver cancer.

Reference

https://www.ncbi.nlm.nih.gov/pubmed/23142287

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
The FDA Expands Use for Gilead Science’s HBV Treatment
2022-11-02
M&A
Xbiome Acquires Ulcerative Colitis Program from Assembly Biosciences
2022-04-29
R&D
Shionogi, NEC Team Up on Hepatitis B Vaccine
2022-04-20
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top